Abstract:We empirically study the endogeneity nature of disclosure quality and the effect of the regulatory reform at the beginning of this century under the Hermalin and Weisback (2009) theoretical framework. Our sample period encompasses two subperiods - the pre-reform subperiod of 1992 to 1999 and the post-reform subperiod of 2004 to 2007. We rank our sample firms into ten deciles based on their cash flow uncertainty (volatility) in the first subperiod. We find that higher cash flow uncertainty deciles have higher accruals and discretionary accruals (proxies for disclosure quality). Moreover, post regulatory reform, only the high cash flow uncertainty deciles experience decline in accruals and discretionary accruals - the higher the uncertainty decile rank, the larger the decline (i.e., the reform appears to be binding on the high cash flow uncertainty deciles).We also document that, post regulatory reform, only the high cash flow uncertainty deciles experience decline in R&D and advertisement expenses (proxy for myopic managerial behaviors) - again, the higher the decile, the larger the decline. Similarly, only the high uncertainty deciles experience reduction in firm valuation (measured by Tobin’s Q) - the higher the uncertainty decile, the larger the reduction. In terms of executive compensation, post reform, higher uncertainty deciles experience a higher degree of increase in CEO compensation ratio (i.e., compensation as a fraction of sales). These results are generally consistent with the predictions of HW (2009).

CEO Confidence and Unreported R&D

CEO Overconfidence, Corporate Governance, and R&D Smoothing in Technology-Based Entrepreneurial Firms

Managerial Ability and R&D Investment: Do CEOs’ and Firms’ Characteristics Matter?

CEO Overconfidence and Earnings Management During Shifting Regulatory Regimes

A behavioral theory of patent application rhythm: The moderating roles of CEO overconfidence and discretion

CEO Overconfidence and firm's R&D investment—Evidence from firm financialization

CEO Foreign Experience and Corporate Financial Investment

CEO Risk Preference and Investing in R&D

Endogenous Information Disclosure and Corporate Governance

CEO Humility and Corporate Social Irresponsibility: Evidence Based on a New Unobtrusive Measure

None of My Business: CEO Financial Career and Corporate Innovation

A Study of the Impact of CEO Turnover on Firm R&D Spending

Endogenous Information Disclosure and Regulatory Reforms

CEO cultural heritage and R&D expenditures

Financial Constraints and R&D Investment: the Moderating Role of CEO Characteristics

CEO Financial Career and Corporate Innovation: Evidence from China

CEO Confidence and Stock Returns

The Real Effect of Financial Disclosure: International Evidence

Administrator-level Differences,Overconfidence and Corporate Investment Decisions

Corporate Innovation and R&D Expenditure Disclosures

CEO Overconfidence and Corporate Innovation Outcomes: Evidence from China